Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longeveron Inc. - Class A Common stock (NQ: LGVN )

1.670 +0.100 (+6.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 189,388
Open 1.600
Bid (Size) 1.620 (4)
Ask (Size) 1.690 (1)
Prev. Close 1.570
Today's Range 1.600 - 1.710
52wk Range 0.7707 - 6.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) CEO to Participate in Fireside Cat at UBS Virtual Organ Restoration and Cell Therapy Day
Via Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa
Via Investor Brand Network
Exposures Product Safety

Performance

YTD
-6.70%
-6.70%
1 Month
-5.11%
-5.11%
3 Month
-13.47%
-13.47%
6 Month
-29.24%
-29.24%
1 Year
-68.49%
-68.49%

More News

Read More
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Alignment with FDA on Development Pathway for Lomecel-B(TM) in HLHS
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Participation at H.C. Wainwright 26th Annual Global Investment Conference
Via Investor Brand Network
Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates
Via InvestorPlace
(LGVN) - Analyzing Longeveron's Short Interest
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
A Look Ahead: Longeveron's Earnings Forecast
Via Benzinga
Peeling Back The Layers: Exploring Longeveron Through Analyst Insights
Via Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
Via Investor Brand Network
Beyond The Numbers: 4 Analysts Discuss Longeveron Stock
Via Benzinga
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Reports on Q2 2024 Financial Results, Business Highlights
Via Investor Brand Network
Exposures Product Safety
LGVN Stock Earnings: Longeveron Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call
Via Investor Brand Network
Exposures Product Safety
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
Via Benzinga
The Top 3 Small-Cap Stocks to Buy Now: Summer 2024
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
Via InvestorPlace
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference
Via Investor Brand Network
Exposures Product Safety
Why Is Alzheimer's-Focused Longeveron Stock Trading Higher On Monday?
Via Benzinga
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.